Skip to content

Interest of a Hybrid Connected Watch for Cardiac Rhythm Monitoring in Post-operative Cardiac Surgery

Single-center Pilot Study to Evaluate the Interest of a Hybrid Connected Watch for Heart Rate Monitoring in Postoperative Cardiac Surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05664308
Acronym
MONHYCARD
Enrollment
106
Registered
2022-12-23
Start date
2024-03-19
Completion date
2028-03-19
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Post Operative Atrial Fibrillation, Connected Watch

Brief summary

The objective of this single-center pilot study is, with the help of a connected watch, to show the absence of recurrence or maintenance of sinus rhythm in patients with a Post Operative Atrial Fibrillation (POAF) and to help treating cardiologists in the care of these patients.

Interventions

OTHERClinical follow-up (ECG)

Clinical follow-up with a consultation at the University Hospital at 3, 6, and 12 months, with an ECG at each visit.

OTHEROngoing monitoring

Once operated, patients will be monitored remotely via a computerized data transfer routine anonymized by the WITHINGS software, based on the data from the watch. It's contractually agreed with WITHINGS that the transmissions will be scheduled and transmitted weekly to the center.

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major with an indication for conventional cardiac surgery with de novo postoperative AF onset. * Agreeing to participate in the study and having signed an informed consent. * Agreeing to undergo 12 months of postoperative monitoring.

Exclusion criteria

* Patient with pre-operative AF * Patient who does not have a smartphone compatible with the connected watch. * Patient unable to perform an ECG measurement independently. * Patient with a physical constraint to the measurement (arteriovenous fistula...) * Minors * Pregnant or breast-feeding women * Adults under guardianship, under curatorship * Patients whose life expectancy is less than 1 year * Patients participating in another therapeutic trial likely to impact the evaluation criteria of the MONHYCARD study * Contraindication to long-term anticoagulants * Patients implanted with a mechanical valve prosthesis pre-operatively or after surgery

Design outcomes

Primary

MeasureTime frameDescription
To compare the rate of recurrence of paroxysmal or persistent atrial fibrillation with continuous 12-month postoperative cardiac surgery monitoring in patients with POAF versus traditional follow-up with ECG recording at 3, 6 and 12 months12 monthsRecurrence rate of paroxysmal or persistent Atrial Fibrillation (AF) (ESC 2020 Definition) over a 12-month follow-up period post cardiac surgery according to traditional ECG monitoring at 3, 6, and 12 months more or less combined with connected watch monitoring

Secondary

MeasureTime frameDescription
Assessment of the rate of patients on anticoagulant therapy by follow-up modality12 monthsRate of anticoagulant use at 3, 6, and 12 months according to rhythm status in both modalities
Evaluation of complication rates related to the different treatments according to the follow-up modality12 monthsCardiovascular mortality, ischemic stroke, anticoagulant-related events
Assessment of the number of patients in AF12 monthsPostoperative AF rate in each group
Assessment of the duration of AF transitions12 monthsPostoperative AF rate over periods of more than 6 hours and/or 12 hours
Assessment of quality of life and satisfaction with use by follow-up modality12 monthsEuropean Quality of Life-5 Dimensions (EQ-5D), (the maximum value is 3 (wich is the worse outcome) and the minimum is 1 (wich is the best outcome)), before intervention, at 3, 6 and 12 months
Evaluate the appropriateness of each of the two modalities with treating cardiologists12 monthsSatisfaction questionnaire for treating cardiologists

Countries

France

Contacts

CONTACTCharles-Henri DAVID
charleshenri.david@chu-nantes.fr02.44.76.85.69
CONTACTImen FELLAH
Imen.FELLAH@chu-nantes.fr02.40.16.51.02

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026